Report cover image

Antispasmodics Drugs Market by Drug type (Dicyclomine Hydrochloride, Hyoscyamine, Loperamide Hydrochloride), Route of administration (Injectable, Oral, Sublingual), Distribution Channel, End-User - Global Forecast 2024-2030

Publisher 360iResearch
Published Jan 15, 2024
Length 199 Pages
SKU # IRE18418426

Description

Antispasmodics Drugs Market by Drug type (Dicyclomine Hydrochloride, Hyoscyamine, Loperamide Hydrochloride), Route of administration (Injectable, Oral, Sublingual), Distribution Channel, End-User - Global Forecast 2024-2030


The Antispasmodics Drugs Market size was estimated at USD 13.57 billion in 2023 and expected to reach USD 14.70 billion in 2024, at a CAGR 8.36% to reach USD 23.83 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Antispasmodics Drugs Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Antispasmodics Drugs Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Antispasmodics Drugs Market, highlighting leading vendors and their innovative profiles. These include Actiza Pharmaceutical Private Limited, Ambrosia Pharma, Amneal Pharmaceuticals LLC, Aurobindo Pharma Limited, B JOSHI AGROCHEM PHARMA, Blue Cross Laboratories Pvt Ltd., Daiichi Sankyo Company, Limited, Dr. Reddys Laboratories Ltd., Flamingo Pharmaceuticals Ltd, Fresenius Kabi AG, GlaxoSmithKline PLC, Hikma Pharmaceuticals PLC, Johnsons & Johnsons Services Inc., Lexicare Pharma Pvt. Ltd., McKesson Medical-Surgical Goverment Solutions LLC, Mylan N.V., Nexus Pharmaceuticals Inc., Noreva Biotech, Pfizer Inc., Sanofi SA, Solitaire Pharmacia Private Limited, Strides Pharma Science Limited, Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, and Wellona Pharma Private Limited.

Market Segmentation & Coverage

This research report categorizes the Antispasmodics Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

Drug type

Dicyclomine Hydrochloride
  • Hyoscyamine
  • Loperamide Hydrochloride
  • Route of administration

    Injectable
  • Oral
  • Sublingual
  • Distribution Channel

    Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy
  • End-User

    Hospitals
  • Speciality Centres
  • Region

    Americas

    Argentina
  • Brazil
  • Canada
  • Mexico
  • United States

    California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas
  • Asia-Pacific

    Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam
  • Europe, Middle East & Africa

    Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom
    The report offers valuable insights on the following aspects:

    1. Market Penetration: It presents comprehensive information on the market provided by key players.
    2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
    3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
    4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
    5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
    The report addresses key questions such as:

    1. What is the market size and forecast of the Antispasmodics Drugs Market?
    2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Antispasmodics Drugs Market?
    3. What are the technology trends and regulatory frameworks in the Antispasmodics Drugs Market?
    4. What is the market share of the leading vendors in the Antispasmodics Drugs Market?
    5. Which modes and strategic moves are suitable for entering the Antispasmodics Drugs Market?


    Note: PDF & Excel + Online Access - 1 Year

    • Table of Contents

    199 Pages
    1. Preface
    1.1. Objectives of the Study
    1.2. Market Segmentation & Coverage
    1.3. Years Considered for the Study
    1.4. Currency & Pricing
    1.5. Language
    1.6. Limitations
    1.7. Assumptions
    1.8. Stakeholders
    2. Research Methodology
    2.1. Define: Research Objective
    2.2. Determine: Research Design
    2.3. Prepare: Research Instrument
    2.4. Collect: Data Source
    2.5. Analyze: Data Interpretation
    2.6. Formulate: Data Verification
    2.7. Publish: Research Report
    2.8. Repeat: Report Update
    3. Executive Summary
    4. Market Overview
    4.1. Introduction
    4.2. Antispasmodics Drugs Market, by Region
    5. Market Insights
    5.1. Market Dynamics
    5.1.1. Drivers
    5.1.1.1. High incidences of irritable bowel syndrome and abdominal problems
    5.1.1.2. Increasing patient awareness level and improvement in treatment
    5.1.1.3. Rising antispasmodic medicines approvals worldwide
    5.1.2. Restraints
    5.1.2.1. Patent expiration issues of antispasmodic drugs
    5.1.3. Opportunities
    5.1.3.1. Growing investment in research and development of novel antispasmodic meds
    5.1.3.2. Investment and expansion of generic drugs production facilities
    5.1.4. Challenges
    5.1.4.1. Inappropriate use of skeletal muscle relaxants in geriatric patients
    5.2. Market Segmentation Analysis
    5.3. Market Trend Analysis
    5.4. Cumulative Impact of High Inflation
    5.5. Porter’s Five Forces Analysis
    5.5.1. Threat of New Entrants
    5.5.2. Threat of Substitutes
    5.5.3. Bargaining Power of Customers
    5.5.4. Bargaining Power of Suppliers
    5.5.5. Industry Rivalry
    5.6. Value Chain & Critical Path Analysis
    5.7. Regulatory Framework
    6. Antispasmodics Drugs Market, by Drug type
    6.1. Introduction
    6.2. Dicyclomine Hydrochloride
    6.3. Hyoscyamine
    6.4. Loperamide Hydrochloride
    7. Antispasmodics Drugs Market, by Route of administration
    7.1. Introduction
    7.2. Injectable
    7.3. Oral
    7.4. Sublingual
    8. Antispasmodics Drugs Market, by Distribution Channel
    8.1. Introduction
    8.2. Hospital Pharmacy
    8.3. Online Pharmacy
    8.4. Retail Pharmacy
    9. Antispasmodics Drugs Market, by End-User
    9.1. Introduction
    9.2. Hospitals
    9.3. Speciality Centres
    10. Americas Antispasmodics Drugs Market
    10.1. Introduction
    10.2. Argentina
    10.3. Brazil
    10.4. Canada
    10.5. Mexico
    10.6. United States
    11. Asia-Pacific Antispasmodics Drugs Market
    11.1. Introduction
    11.2. Australia
    11.3. China
    11.4. India
    11.5. Indonesia
    11.6. Japan
    11.7. Malaysia
    11.8. Philippines
    11.9. Singapore
    11.10. South Korea
    11.11. Taiwan
    11.12. Thailand
    11.13. Vietnam
    12. Europe, Middle East & Africa Antispasmodics Drugs Market
    12.1. Introduction
    12.2. Denmark
    12.3. Egypt
    12.4. Finland
    12.5. France
    12.6. Germany
    12.7. Israel
    12.8. Italy
    12.9. Netherlands
    12.10. Nigeria
    12.11. Norway
    12.12. Poland
    12.13. Qatar
    12.14. Russia
    12.15. Saudi Arabia
    12.16. South Africa
    12.17. Spain
    12.18. Sweden
    12.19. Switzerland
    12.20. Turkey
    12.21. United Arab Emirates
    12.22. United Kingdom
    13. Competitive Landscape
    13.1. FPNV Positioning Matrix
    13.2. Market Share Analysis, By Key Player
    13.3. Competitive Scenario Analysis, By Key Player
    14. Competitive Portfolio
    14.1. Key Company Profiles
    14.1.1. Actiza Pharmaceutical Private Limited
    14.1.2. Ambrosia Pharma
    14.1.3. Amneal Pharmaceuticals LLC
    14.1.4. Aurobindo Pharma Limited
    14.1.5. B JOSHI AGROCHEM PHARMA
    14.1.6. Blue Cross Laboratories Pvt Ltd.
    14.1.7. Daiichi Sankyo Company, Limited
    14.1.8. Dr. Reddys Laboratories Ltd.
    14.1.9. Flamingo Pharmaceuticals Ltd
    14.1.10. Fresenius Kabi AG
    14.1.11. GlaxoSmithKline PLC
    14.1.12. Hikma Pharmaceuticals PLC
    14.1.13. Johnsons & Johnsons Services Inc.
    14.1.14. Lexicare Pharma Pvt. Ltd.
    14.1.15. McKesson Medical-Surgical Goverment Solutions LLC
    14.1.16. Mylan N.V.
    14.1.17. Nexus Pharmaceuticals Inc.
    14.1.18. Noreva Biotech
    14.1.19. Pfizer Inc.
    14.1.20. Sanofi SA
    14.1.21. Solitaire Pharmacia Private Limited
    14.1.22. Strides Pharma Science Limited
    14.1.23. Sun Pharmaceutical Industries Ltd.
    14.1.24. Takeda Pharmaceutical Company Limited
    14.1.25. Wellona Pharma Private Limited
    14.2. Key Product Portfolio
    15. Appendix
    15.1. Discussion Guide
    15.2. License & Pricing
    FIGURE 1. ANTISPASMODICS DRUGS MARKET RESEARCH PROCESS
    FIGURE 2. ANTISPASMODICS DRUGS MARKET SIZE, 2023 VS 2030
    FIGURE 3. ANTISPASMODICS DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
    FIGURE 4. ANTISPASMODICS DRUGS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
    FIGURE 5. ANTISPASMODICS DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 6. ANTISPASMODICS DRUGS MARKET DYNAMICS
    FIGURE 7. ANTISPASMODICS DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
    FIGURE 8. ANTISPASMODICS DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 9. ANTISPASMODICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
    FIGURE 10. ANTISPASMODICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 11. ANTISPASMODICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
    FIGURE 12. ANTISPASMODICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 13. ANTISPASMODICS DRUGS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
    FIGURE 14. ANTISPASMODICS DRUGS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 15. AMERICAS ANTISPASMODICS DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    FIGURE 16. AMERICAS ANTISPASMODICS DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 17. UNITED STATES ANTISPASMODICS DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
    FIGURE 18. UNITED STATES ANTISPASMODICS DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 19. ASIA-PACIFIC ANTISPASMODICS DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    FIGURE 20. ASIA-PACIFIC ANTISPASMODICS DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ANTISPASMODICS DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ANTISPASMODICS DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 23. ANTISPASMODICS DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
    FIGURE 24. ANTISPASMODICS DRUGS MARKET SHARE, BY KEY PLAYER, 2023

    Pricing

    Currency Rates
    How Do Licenses Work?

    How Do Licenses Work?

    The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

    • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

    • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

    • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

    • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

    • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

    License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

    Head shot

    Questions or Comments?

    Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
    Chat Now
    Contact Us